Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
O pacijentima koji se podvrgavaju ambulantnoj CAR T-staničnoj terapiji raka mora brinuti multidisciplinarni tim koji uključuje medicinske sestre koordinatore, prema posteru predstavljenom na 49. godišnjoj konferenciji onkološkog medicinskog društva. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
Svibanj 2023.: T-stanična terapija kimernim antigenskim receptorom (CAR) inovativan je razvoj u području individualizirane terapije raka. Pacijentove vlastite T-stanice su genetski modificirane tijekom procesa proizvodnje kako bi eksprimirale...
Ožujak 2023.: Prvo poglavlje memoara Sama Neilla bilo bi golem šok za nekoga tko nije imao prethodnog znanja o tome. Počinje dovoljno smiješno: sjajna priča o njegovoj kćeri Eleni koja je ispitivana o očevom poslu.
Ožujak 2023.: Kratki sažetak: Svrha ovog kliničkog ispitivanja je otkriti može li se terapija CAR T-stanicama anti-MESO antigen receptora koristiti za liječenje epitelnog raka jajnika koji se vratio ili je prestao reagirati na druge.